Trial intelligence / Profile preview

BIBR 277 Pharmacokinetics in Hypertensive Patients

NCT02187497Phase 2Completed

Sponsor
Boehringer Ingelheim
Start
Jun 1998
Primary completion
Sep 1998
Modality
Small Molecules
01

Overview

A Phase 2 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Jun 1998; status: completed.

02

Drugs

telmisartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02187497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02187497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call